---
title: "Incannex Reactivates Share Buyback, Signaling Valuation Confidence"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280799162.md"
description: "Incannex Reactivates Share Buyback, Signaling Valuation Confidence"
datetime: "2026-03-27T13:17:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280799162.md)
  - [en](https://longbridge.com/en/news/280799162.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280799162.md)
---

# Incannex Reactivates Share Buyback, Signaling Valuation Confidence

Incannex Reactivates Share Buyback, Signaling Valuation Confidence

### Related Stocks

- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IXHL.US](https://longbridge.com/en/quote/IXHL.US.md)
- [PSIL.US](https://longbridge.com/en/quote/PSIL.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [LABD.US](https://longbridge.com/en/quote/LABD.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)

## Related News & Research

- [Vertex Says Health Canada Accepts Suzetrigine Application for Review](https://longbridge.com/en/news/287257602.md)
- [Neurothera Labs Announces Adoption of Semi-Annual Reporting](https://longbridge.com/en/news/287119698.md)
- [AbbVie Inc. $ABBV Shares Purchased by RiverFront Investment Group LLC](https://longbridge.com/en/news/286750290.md)
- [Shah Capital Management Will Vote ‘No' Across Five Proposals On Novavax's June 18 Ballot - SEC Filing](https://longbridge.com/en/news/286565204.md)
- [<![CDATA[Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates]]>](https://longbridge.com/en/news/286787081.md)